ARTICLE | Management Tracks
Camerini steps down as Cosmo CSO; plus CytoDyn, G1 Therapeutics, Flexion and Clearside
March 13, 2020 10:03 PM UTC
Gastrointestinal disorders company Cosmo Pharmaceuticals N.V. (SIX:COPN) said CSO Roberto Camerini has resigned. Luigi Moro, who was Cosmo's CSO from 1999-2019, will come out of retirement to serve as interim CSO until a permanent successor is found.
CytoDyn Inc. (OTCQB:CYDY) hired Jacob Lalezari as interim CMO. Lalezari, who is CEO and director of Quest Clinical Research, is heading up the antiviral company's efforts to begin testing its CCR5 antagonist leronlimab in a COVID-19 clinical trial...